Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,145	$ 4,299
Accounts receivable, net of allowance for credit losses of $107 and $111, respectively	4,546	5,536
Inventory	7,614	7,930
Other current assets	4,431	4,403
Total current assets	19,736	22,168
Property, plant and equipment, net	2,774	2,546
Goodwill	8,541	6,803
Other non-current assets	7,443	7,088
Total assets	38,494	38,605
Current liabilities:
Notes payable and short-term borrowings	218	1,106
Accounts payable	15,303	16,075
Other current liabilities	10,668	11,880
Total current liabilities	26,189	29,061
Long-term debt	10,796	6,386
Other non-current liabilities	4,534	4,802
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 980 and 1,092 shares issued and outstanding at October 31, 2022, and 2021 respectively)	10	11
Additional paid-in capital	1,172	1,060
Accumulated deficit	(4,492)	(2,470)
Accumulated other comprehensive income (loss)	285	(245)
Total stockholders’ deficit	(3,025)	(1,644)
Total liabilities and stockholders’ deficit	$ 38,494	$ 38,605